DPPIV

(redirected from Dipeptidyl Peptidase IV)
Also found in: Medical.
AcronymDefinition
DPPIVDipeptidyl Peptidase IV
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Cheon et al., "A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing [beta]-cell replication and neogenesis," Diabetes Research and Clinical Practice, vol.
[3] Nonstandard abbreviations: HF, heart failure; BNP, B-type natriuretic peptide; NT-proBNP, amino-terminal proBNP; DPP-IV, dipeptidyl peptidase IV; RIA, radioimmunoassay; IQR, interquartile range.
Yang, "Inhibition of dipeptidyl peptidase IV protects tacrolimus-induced kidney injury," Laboratory Investigation, vol.
Cheon et al., "A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocininduced diabetes by increasing [beta]-cell replication and neogenesis," Diabetes Research and Clinical Practice, vol.
Glucagon-like peptide-1-(7-36)amide is transformed to glucagonlike peptide-l-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L ceils of the porcine intestine.
Coverage includes salivary biomarkers, tumor markers in pseudopodia for invasive migration, intraocular lymphoma markers, serum tumor markers in breast cancer, diagnostic classification using gene expression profiling in AML, tumor antigens as markers of minimal residual disease in acute myeloid leukemia, activity and expression of dipeptidyl peptidase IV and cathepsin H in human cutaneous melanoma compared to other common cancers, ovarian cancer detection, comparison of the prognostic association of nucleolar size between uveal and conjunctival melanoma, biomarkers of hepatocellular carcinoma, cell adhesive markers in metastasizing colorectal carcinoma, and fetal hemoglobin as an oncofetal marker.
Januvia does this by blocking an enzyme (dipeptidyl peptidase IV or DPP-IV) which breaks down these proteins, leading to better blood sugar control.
Tokyo, Japan, June 15, 2006 - (JCN) - Ono Pharmaceutical and Banyu Pharmaceutical have obtained positive results in the recent clinical trials of sitagliptin, a dipeptidyl peptidase IV (DPP4) inhibitor.
Incretin mimetics, dipeptidyl peptidase IV (DPP-IV) inhibitors, dual peroxisome proliferator-activated receptor (PPAR) activators, amylin analogues, and cannabinoid receptor blockers--not to mention inhaled forms of insulin--are all wending their way through clinical trials.
(OSI) Prosidion's lead compound, PSN9301, is a Dipeptidyl Peptidase IV (DPIV) inhibitor currently in Phase II clinical trials.
The rights to the dipeptidyl peptidase IV inhibitors had earlier been shared between PPD and Syrrx Inc., which Takeda turned into a subsidiary and renamed it Takeda San Diego Inc.
Full browser ?